Researchers say ‘relatively simple, inexpensive’ means of assessing genetic risk offers hope of better screening
An at-home spit test appears to perform better at predicting prostate cancer risk than the current frontline test, a study suggests.
The test assesses 130 genetic variants to provide a risk score for prostate cancer, which is the second most common cause of cancer deaths in men in the UK.
More Stories
AI can be more persuasive than humans in debates, scientists find
Starwatch: Boötes, the herdsman ploughing the heavens
Bankrupt DNA testing firm 23andMe to be purchased for $256m